Recall: Par Pharmaceutical Mycophenolate Mofetil For Injection
On 2019-05-01, the FDA announced that Par Pharmaceutical is conducting a recall on Mycophenolate Mofetil For Injection due to possible contamination with . The recalled products were sold under the brand name(s) Par Pharmaceutical during an unspecified time period throughout the regions shown in the map below.
In recent months, there have been 4 drugs recalls due to potential contamination, including losartan potassium tablets, usp; losartan potassium and hydrochlorothiazide tablets, usp, baby cough syrup + mucus and more. Additionally, there have been 26 drug and medical device recalls due to other health hazards as well as 77 food recalls.
Company Contact Information:
Name: Par Pharmaceutical
Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.
Detailed Recall Information
Regions Where Sold: Nationwide
Product Description: Mycophenolate Mofetil for Injection
Brand Name(s): Par Pharmaceutical
Reason for Recall: Foreign Material Contamination
Official Recall Date: 2019-05-01
Additional information provided by the FDA.gov:
Endo International plc, announced today that one of its operating companies, Par Pharmaceutical, Inc., is voluntarily recalling one lot of Mycophenolate Mofetil for Injection, USP to the hospital and retail pharmacy level. One vial of product was observed containing a glass fragment after reconstitution. Read More.
More information may be available at FDA.gov
Latest Safety Recalls
Select image for details, including additional styles.
Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.